Effect of research and development outsourcing on new drug approvals in the pharmaceutical industry. Issue 1 (26th December 2012)

• Record Type: Journal Article
• Authors: Banerjee, Tannista; Nayak, Arnab
• Is Part Of: Journal of pharmaceutical health services research. Volume 4:Issue 1(2013:Mar.)
• Page Start: 51
• Page End: 56
• Publication Date: 2012-12-26
• Subjects: Pharmacy -- Research -- Periodicals; Drugs -- Research -- Periodicals; Medical care -- Research -- Periodicals; Public health -- Research -- Periodicals; Pharmaceutical industry -- Periodicals; Health Services Research -- Periodicals; Economics, Pharmaceutical -- Periodicals; 615.1072
• DOI: 10.1111/jphs.12003
• Languages: English
• ISSNs: 1759-8885

Abstract

<abstract abstract-type="main"> <title>Abstract</title> <sec id="jphs12003-sec-0001" sec-type="section"> <title>Objectives</title> <p>This paper studies the relationship between the outsourcing of research and development activities in the pharmaceutical industry and the approval of new drug applications by the US Food and Drug Administration.</p> </sec> <sec id="jphs12003-sec-0002" sec-type="section"> <title>Methods</title> <p>We controlled for the unobserved company‐specific effect and other econometric issues. Unique company‐level pharmaceutical outsourcing data were used for the period from 1995–2006.</p> </sec> <sec id="jphs12003-sec-0003" sec-type="section"> <title>Key findings and conclusions</title> <p>Results show that contemporaneous, one and two periods lagged outsourcing are more helpful than early outsourcing in getting successful new drug applications. The study also shows the importance of the sales figures of a company in relation to its likelihood of introducing a new drug onto the market.</p> </sec> </abstract>